Home › Autoimmune Diseases › NCT06469788
Testimonials and Navigation in Rheumatology
Recruiting
Improving COVID-19 Vaccine Uptake Among Racial and Ethnic Minority Groups With Rheumatic Diseases
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Adults (18+ years) with known AIRD * Black race and/or Latinx ethnicity * Individuals who have not obtained the updated COVID-19 vaccine series (self-report) Exclusion Criteria: -Lack of access to phone
About the study
The overall goal of this study is to determine whether a novel, multi-modal, patient-directed behavioral intervention initiated in rheumatology clinics is an effective approach to improve uptake of updated COVID-19 vaccine.
What is being tested
- Video comprised of AIRD patient narratives on COVID-19 vaccination thoughts and experiences (behavioral)
- Video on the importance of good oral health for patients with AIRD (behavioral)
- Brochure on COVID-19 vaccination in AIRD patients (behavioral)
- Patient Navigation (behavioral)
- Brochure on the importance of good oral health in AIRD patients (behavioral)
Sponsor: University of Alabama at Birmingham · Participants: 1,170 · Started: Dec 18, 2024
Contact the study team
- Mary A Wilkenson, Clinical Research Coordinator, BS · Phone: 205-996-7875
Official record on ClinicalTrials.gov — NCT06469788
Locations in the U.S.
| Alabama | University of Alabama at Birmingham, Birmingham |
| Illinois | Northwestern University, Evanston |
| Massachusetts | Brigham Women's Hospital, Boston University of Massachusetts Chan Medical School, Worcester |
Conditions
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.